Regulation of interleukin-1 in acute brain injury.
暂无分享,去创建一个
[1] S. Akira,et al. Addendum: Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production , 2013, Nature Immunology.
[2] G. López-Castejón,et al. Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules , 2011, Cellular and Molecular Life Sciences.
[3] A. Algra,et al. Excess Mortality and Cardiovascular Events in Patients Surviving Subarachnoid Hemorrhage: A Nationwide Study in Sweden , 2011, Stroke.
[4] M. Lamkanfi. Emerging inflammasome effector mechanisms , 2011, Nature Reviews Immunology.
[5] K. Herholz,et al. Brain inflammation is induced by co-morbidities and risk factors for stroke , 2011, Brain, Behavior, and Immunity.
[6] C. Serhan,et al. Specialized pro-resolving lipid mediators in the inflammatory response: An update. , 2010, Biochimica et biophysica acta.
[7] Grace Y Chen,et al. Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.
[8] Denis Gris,et al. The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18 , 2010, The Journal of Neuroscience.
[9] Egil Lien,et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.
[10] N. Rothwell,et al. Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] M. Schwartz,et al. Systemic inflammatory cells fight off neurodegenerative disease , 2010, Nature Reviews Neurology.
[12] B. McColl,et al. Platelet interleukin-1alpha drives cerebrovascular inflammation. , 2010, Blood.
[13] M. Shipston,et al. A Role for Potassium Permeability in the Recognition, Clearance, and Anti-inflammatory Effects of Apoptotic Cells , 2010, Molecular Neurobiology.
[14] K. Rock,et al. Identification of the Cellular Sensor That Stimulates the Inflammatory Response to Sterile Cell Death , 2010, The Journal of Immunology.
[15] Fernando Ontiveros,et al. The sterile inflammatory response. , 2010, Annual review of immunology.
[16] C. Dinarello. Anti-inflammatory Agents: Present and Future , 2010, Cell.
[17] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[18] V. Hornung,et al. Critical functions of priming and lysosomal damage for NLRP3 activation , 2010, European journal of immunology.
[19] F. Martinon. Signaling by ROS drives inflammasome activation , 2010, European journal of immunology.
[20] F. Sutterwala,et al. Sterile inflammatory responses mediated by the NLRP3 inflammasome , 2010, European journal of immunology.
[21] Jiping Tang,et al. Ac-YVAD-CMK Decreases Blood–Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1β in Intracerebral Hemorrhage Mouse Model , 2010, Translational Stroke Research.
[22] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[23] Y. Carmi,et al. Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation , 2010, Proceedings of the National Academy of Sciences.
[24] F. Sutterwala,et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome , 2009, Proceedings of the National Academy of Sciences.
[25] John H. Zhang,et al. Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice , 2009, Stroke.
[26] B. McColl,et al. Nuclear retention of IL‐1α by necrotic cells: A mechanism to dampen sterile inflammation , 2009, European journal of immunology.
[27] V. Dixit,et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome , 2009, The Journal of cell biology.
[28] R. Dana,et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. , 2009, Investigative ophthalmology & visual science.
[29] F. Re,et al. Cutting Edge: Necrosis Activates the NLRP3 Inflammasome1 , 2009, The Journal of Immunology.
[30] D. Brough,et al. Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy , 2009, British journal of pharmacology.
[31] D. Seyfried,et al. A novel calpastatin-based inhibitor improves postischemic neurological recovery. , 2009, Biochemical and biophysical research communications.
[32] Steffen Jung,et al. Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice , 2009, PLoS medicine.
[33] C. Eder. Mechanisms of interleukin-1beta release. , 2009, Immunobiology.
[34] A. Surprenant,et al. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates , 2009, The EMBO journal.
[35] J. Lehár,et al. Synergistic drug combinations improve therapeutic selectivity , 2009, Nature Biotechnology.
[36] Marc Fisher,et al. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.
[37] H. Bramlett,et al. Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] Y. Yin,et al. Inflammasomes are Differentially Expressed in Cardiovascular and other Tissues , 2009, International journal of immunopathology and pharmacology.
[39] J. P. de Rivero Vaccari,et al. Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] Catherine Rabouille,et al. Mechanisms of regulated unconventional protein secretion , 2009, Nature Reviews Molecular Cell Biology.
[41] F. Sutterwala,et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. , 2009, The Journal of clinical investigation.
[42] J. Simard,et al. Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke , 2009, Stroke.
[43] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[44] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[45] K. Moore,et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.
[46] C. Haslett,et al. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. , 2008, Trends in pharmacological sciences.
[47] S. Hopkins,et al. Acute ischaemic stroke and infection: recent and emerging concepts , 2008, The Lancet Neurology.
[48] J. P. de Rivero Vaccari,et al. A Molecular Platform in Neurons Regulates Inflammation after Spinal Cord Injury , 2008, The Journal of Neuroscience.
[49] N. Rothwell,et al. Interleukin-1 Receptor Antagonist Penetrates Human Brain at Experimentally Therapeutic Concentrations , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] N. Rothwell,et al. The Dynamics and Mechanisms of Interleukin-1α and β Nuclear Import , 2008, Traffic.
[51] C. Andry,et al. Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis In Vivo1 , 2007, The Journal of Immunology.
[52] N. Rothwell,et al. A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat , 2007, Neuropharmacology.
[53] F. Martinon,et al. Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[54] T. Gasser,et al. ANALYSIS OF INTRATHECAL INTERLEUKIN‐6 AS A POTENTIAL PREDICTIVE FACTOR FOR VASOSPASM IN SUBARACHNOID HEMORRHAGE , 2007, Neurosurgery.
[55] N. Rothwell,et al. Caspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell death , 2007, Journal of Cell Science.
[56] G. Hankey. Potential New Risk Factors for Ischemic Stroke: What Is Their Potential? , 2006, Stroke.
[57] G. Donnan,et al. 1,026 Experimental treatments in acute stroke , 2006, Annals of neurology.
[58] M. T. Hasan,et al. IKK mediates ischemia-induced neuronal death , 2005, Nature Medicine.
[59] N. Rothwell,et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[60] N. Rothwell,et al. Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.
[61] J. Braudeau,et al. Activation of Proinflammatory Caspases by Cathepsin B in Focal Cerebral Ischemia , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[62] D. E. Goll,et al. The calpain system. , 2003, Physiological reviews.
[63] R. Soldi,et al. S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells , 2003, Journal of Cell Science.
[64] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[65] S. Kassis,et al. Inhibition of p38 mitogen‐activated protein kinase provides neuroprotection in cerebral focal ischemia , 2001, Medicinal research reviews.
[66] Y. Itoyama,et al. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. , 1995, Stroke.
[67] J. Tschopp,et al. The Inflammasomes , 2010, Cell.